There was an opinion calling for expediting the expansion of the benefit standard for tumor-agnostic therapy.

Independent lawmaker Lee Yong-ho said in a parliamentary audit of the National Assembly's Health and Welfare Committee on the 15th, "Benefits of Keytruda & Tagrisso have not expanded and are causing pain to patients," adding, "Keytruda's first lung cancer benefit has not been expanded for four years. I think many patients would have lived during that period."

Han Hyun-ho, a clinical assistant professor at Yonsei University's urology department, who attended as a reference at the request of lawmaker Lee, demanded the urology benefit of Keytruda.

Professor Han said,